JACANA, a vertically integrated cannabis and wellness company, has announced the successful completion of its first medical cannabis export to the Cayman Islands, shipped January 7, 2026. The shipment marks a milestone in JACANA's international expansion strategy and establishes a repeatable, compliant export pathway for medical cannabis exports into regulated markets.
The export was completed under a fully regulated bilateral framework, authorized by import permits from the Cayman Islands Chief Medical Officer (CMO) and an export permit from Jamaica's Cannabis Licensing Authority (CLA). The products have been imported by Caribbean Medical Distributors Ltd and will be available to patients via prescription through pharmacies and hospitals across the Cayman Islands.
This shipment also introduces Cayman patients to sun-grown, organically cultivated Jamaican cannabis, offering a natural alternative to indoor-grown imports that dominate many medical markets today.
"This export validates what we've been building at JACANA: a compliant, scalable international distribution platform capable of delivering plant medicines to medical and consumer markets worldwide," said Alexandra Chong, CEO of JACANA. "As a Caribbean company, there's something meaningful about bringing Jamaican cannabis to patients across our region. It's a connection rooted in our shared culture and history. We've already proven our multi-market capabilities in Wellness, with distribution spanning the Caribbean, the United States, and Europe. This Cayman shipment does the same for medical cannabis. It's a model we intend to deploy across additional regulated markets."
"Reliable, compliant supply is critical to patient access," said David Pellow, Director at Caribbean Medical Distributors Ltd. "We are pleased to partner with JACANA to make sun-grown Jamaican medical cannabis available to patients across the Cayman Islands."
For more information:
JACANA Wellness
Email: [email protected]
jacanawellness.com/
